Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Degano, B.
Right arrow Articles by Arnal, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Degano, B.
Right arrow Articles by Arnal, J.-F.
(Chest. 2005;128:1699-1705.)
© 2005 American College of Chest Physicians

Effect of Treatment on Maxillary Sinus and Nasal Nitric Oxide Concentrations in Patients With Nosocomial Maxillary Sinusitis*

Bruno Degano, MD; Michèle Génestal, MD; Elie Serrano, MD; Jacques Rami, PhD and Jean-François Arnal, MD, PhD

* From Service de Pneumologie (Dr. Degano), Service d’Otorhinolaryngologie (Dr. Serrano), and Service d’Exploration Fonctionnelle Respiratoire (Dr. Rami), CHU Larrey, Toulouse, France; INSERM U589 (Dr. Arnal), CHU Rangueil, Toulouse, France; and Unité de Réanimation Polyvalente et Hyperbare (Dr. Génestal), CHU Purpan, France.

Correspondence to: Bruno Degano, MD, CHU Larrey, TSA 30030, 31059 Toulouse Cedex 4, France; e-mail: degano.b{at}chu-toulouse.fr

Study objectives: In maxillary nosocomial sinusitis (MNS) related to severe sepsis, nitric oxide (NO) concentration in the maxillary sinuses is drastically reduced secondarily to a downregulation of type-2 NO synthase. NO plays a major role in nonspecific immune defense of sinuses. We therefore aimed to study maxillary NO concentration during the treatment of MNS with drainage, daily lavage, and removal of any nasally introduced tube.

Patients and methods: Nine patients were studied during the first 4 days of treatment of MNS. We measured the concentration of NO gas in the maxillary sinus and in the nasal cavity, and the NO metabolite levels (nitrites/nitrates [NOx]) in the sinus lavages.

Measurements and results: Maxillary NO concentration (median [25 to 75 percentile]) increased from 70 parts per billion (ppb) [40 to 100 ppb] to 2,050 ppb (1,700 to 3,000 ppb) after 4 days of treatment of MNS (p < 0.0001). In the meantime, nasal NO increased from a median of 100 ppb (98 to 148 ppb) to 180 ppb (180 to 188 ppb) [p < 0.001]. At any time, there was a correlation between maxillary NO (logarithmic value) and nasal NO (r2 = 0.57, p < 0.0001). NOx levels remained stable in the lavages.

Conclusions: We conclude that the treatment of the sinusitis with drainage, daily lavage, and removal of the gastric tube lead to a spectacular increase of maxillary and nasal NO concentrations.

Key Words: nitric oxide • nosocomial maxillary sinusitis • sepsis






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.